04 May 2026
Researchers at the Champalimaud Foundation, in Lisbon, have for the first time managed to identify, with an imaging technique, whether nervous impulses in the brain of rats are flowing in a “bottom-up” (feedforward), carrying information about visual input, or a “top-down” (feedback) direction, carrying information about expectations or predictions on a given task or about the perception of the world around us.
28 April 2026
Signed in Rome on 28 April, the agreement combines the Champalimaud Foundation’s expertise in adult oncology with Bambino Gesù’s recognised leadership in paediatric oncology and cell therapies. This synergy strengthens the link between research and clinical practice throughout the translational medicine pathway.
29 April 2026
The Teaching Lab is much more than a classroom. It’s where students, from their first experiments to their PhDs, develop the confidence to ask questions and test ideas.
Used daily by researchers and students alike, this space is a hub for building and refining scientific setups, and a venue for workshops and courses that welcome new minds every year.
It has reshaped how science is done at the Champalimaud Foundation. By empowering students, it strengthens entire research teams.
The symposium will bring together national and international experts to explore the dynamic evolution of the field, with a special focus on the close collaboration between radiology and surgery.
Diagnostic and interventional radiology are currently undergoing remarkable transformation. New imaging methodologies are redefining precision and diagnostic capability, achieving unprecedented levels of accuracy and clinical impact. Innovations such as photon-counting CT technology and ultra-fast MRI protocols are rapidly expanding the horizons of medical imaging.
20 April 2026
The three-year grant, worth $1 million, is part of the largest-ever grant programme launched by the American Association for Cancer Research (AACR), which aims to support promising scientists at critical junctures in their careers. Correia was one of 15 researchers selected to share a total of $15 million to pursue paradigm-shifting ideas in cancer biology, with the ultimate aim of improving patient outcomes.
She is the only awardee based in Portugal and one of a small number of researchers selected outside the United States.
Eugenia Chiappe, Sensorimotor Integration Lab
Christa Rhiner, Stem Cells and Regeneration Lab
Albino Oliveira-Maia, Neuropsychiatry